| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.091 | 0.002 |